Escitalopram vs Norethindrone: side-by-side comparison
Escitalopram (Selective serotonin reuptake inhibitor (SSRI)) and Norethindrone (Progestin) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Escitalopram | Norethindrone |
|---|---|---|
| Therapeutic class | Selective serotonin reuptake inhibitor (SSRI) | Progestin |
| CAS | 128196-01-0 | 68-22-4 |
| ATC | N06AB10 | G03DC02 |
| Molecular weight | 324.39 g/mol | 298.42 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Escitalopram and Norethindrone share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Escitalopram acts by a different mechanism than Norethindrone, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Escitalopram: Escitalopram selectively inhibits the serotonin reuptake transporter (SERT) at the synaptic cleft, increasing serotonin availability for postsynaptic receptors. Norethindrone: Norethindrone binds to progesterone receptors and exerts progestational effects: thickening cervical mucus, suppressing the LH surge, thinning the endometrium and inhibiting ovulation (at sufficient doses).
Indications compared
Escitalopram: Escitalopram is approved for major depressive disorder, generalised anxiety disorder, social anxiety disorder, panic disorder and obsessive-compulsive disorder, with regional variation in licensing. Norethindrone: Norethindrone is approved for prevention of pregnancy (progestin-only and combined formulations), secondary amenorrhoea, abnormal uterine bleeding, endometriosis-associated pain, and as part of menopausal hormone replace…
Safety profile
Escitalopram: Common adverse effects include nausea, headache, sexual dysfunction, fatigue, sleep disturbance and increased sweating, most prominent in the first 2–4 weeks. Norethindrone: Common adverse effects include breakthrough bleeding, breast tenderness, nausea, mood changes and headache.
Frequently asked questions
Is Escitalopram better than Norethindrone? ▾
Escitalopram and Norethindrone are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Escitalopram and Norethindrone be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Escitalopram
Products with Norethindrone
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.